Intellipharmaceutics International Inc. (IPCI)

[AngeloFoca]

Let's try and get an idea as to what we can expect from Focalin royalties on 25mg and 35mg for the 6 months exclusivity period.

We know that those 2 doses account for $80 million yearly... and we know that the Focalin market as a whole dropped to $760 million from $1.2 Billion or 63.33%... so we can assume the $80 million will drop to ~ $51 million once generics hit the market.

we also know that PAR captured 43% of the market for previous exclusivity on the 15mg and 30 mg... so we can safely assume the same will happen again, so 43% of $51 million = ~ $22 million which we can expect PAR to rake in for the year or $5.5 million per quarter... possibly even more for the first 2 quarters.

From previous napkin figuring and assumptions, I once deducted that IPCI appears to get either 2.5% or 5% royalties on a continuous basis... BUT gets 10% royalties during the 180 days exclusivity period... therefore IPCI should be getting $550,000 per quarter for the next 2 quarters on the 25mg and 35mg + add to that the $560,000 it now gets for the 15mg and 30mg and IPCI's royalties should be over $1.1 million for each of the 2nd and 3rd quarter.